Sohonos (palovarotene)

pCPA File Number: 22384

Negotiation Status:

Active Negotiation

Indication(s):

Fibrodysplasia Ossificans Progressiva

Sponsor/Manufacturer:

Ipsen Biopharmaceuticals Canada, Inc.

CDA-AMC Project Number:

SR0761-000

pCPA Engagement Letter Issued:

2023-12-20

Negotiation Process Concluded:

Not Applicable